Anti-BTN3A1 + BTN3A2 + BTN3A3 antibody [EPR28070-58] - BSA and Azide free
- Recombinant
- RabMAb
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal BTN3A1 antibody. Carrier free. Suitable for Dot, Flow Cyt, ICC/IF and reacts with Recombinant fragment - Human, Human samples.
View Alternative Names
CD277, BTF5, BTN3A1, Butyrophilin subfamily 3 member A1, BT3.2, BTF3, BTF4, BTN3A2, Butyrophilin subfamily 3 member A2, BTF3, BTN3A3, Butyrophilin subfamily 3 member A3
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-BTN3A1 + BTN3A2 + BTN3A3 antibody [EPR28070-58] - BSA and Azide free (AB319102)
This data was developed using ab319101, the same antibody clone in a different buffer formulation.
Flow cytometric analysis of Human PBMC (human peripheral blood mononuclear cell) cells labelling BTN3A1 + BTN3A2 + BTN3A3 with ab319101 at 1/50 dilution (1ug) / Right compared with a Rabbit monoclonal IgG (ab172730) / Left isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody).
Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/5000 dilution was used as the secondary antibody.
Gated on viable cells.
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-BTN3A1 + BTN3A2 + BTN3A3 antibody [EPR28070-58] - BSA and Azide free (AB319102)
This data was developed using ab319101, the same antibody clone in a different buffer formulation.
Flow cytometric analysis of HeLa (human cervical adenocarcinoma epithelial cell) (Right) / MCF7 (human breast adenocarcinoma epithelial cell) (Left) cells labelling BTN3A1 + BTN3A2 + BTN3A3 with ab319101 at 1/50 dilution (1ug) (Magenta) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody).
Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/5000 dilution was used as the secondary antibody.
Gated on viable cells.
Low expression : MCF7.
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-BTN3A1 + BTN3A2 + BTN3A3 antibody [EPR28070-58] - BSA and Azide free (AB319102)
This data was developed using ab319101, the same antibody clone in a different buffer formulation.
Flow cytometric analysis of Jurkat (human T cell leukemia T lymphocyte from peripheral blood) (Right) / Caco-2 (human colorectal adenocarcinoma epithelial cell) (Left) cells labelling BTN3A1 + BTN3A2 + BTN3A3 with ab319101 at 1/50 dilution (1ug) (Magenta) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody).
Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/5000 dilution was used as the secondary antibody.
Gated on viable cells.
Low expression : Caco-2.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-BTN3A1 + BTN3A2 + BTN3A3 antibody [EPR28070-58] - BSA and Azide free (AB319102)
This data was developed using ab319101, the same antibody clone in a different buffer formulation.
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized Human PBMC (human peripheral blood mononuclear cell) cells labelling BTN3A1 + BTN3A2 + BTN3A3 with ab319101 at 1/50 (10.52 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2 ug/mL dilution (Green).
Confocal image showing cytoplasmic staining in human PBMC (shown in green). The counterstain was observed in magenta. Nuclear DNA was labeled with DAPI (shown in blue). Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
Anti-rat CD3 mouse monoclonal antibody (Alexa Fluor® 647) was used to counterstain tubulin at 1/100 5ug/ml dilution (Magenta). The Nuclear counterstain was DAPI (Blue).
Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/mL dilution.
- Dot
Supplier Data
Dot Blot - Anti-BTN3A1 + BTN3A2 + BTN3A3 antibody [EPR28070-58] - BSA and Azide free (AB319102)
This data was developed using ab319101, the same antibody clone in a different buffer formulation.
Dot blot analysis of BTN3A1 + BTN3A2 + BTN3A3 using ab319101 at 1 : 1000 (0.526 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution.
Lane1 : Human BTN3A1 recombinant protein
Lane2 : His-tagged human BTN3A2 recombinant protein
Lane3 : His-tagged human BTN3A3 recombinant protein
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
This antibody recognizes BTN3A1, BTN3A2 and BTN3A3.
All lanes:
Dot Blot - Anti-BTN3A1 + BTN3A2 + BTN3A3 antibody [EPR28070-58] (<a href='/en-us/products/primary-antibodies/btn3a1-btn3a2-btn3a3-antibody-epr28070-58-ab319101'>ab319101</a>) at 1/1000 dilution
Lane 1:
Human BTN3A1 recombinant protein
Lane 2:
His-tagged human BTN3A2 recombinant protein
Lane 3:
His-tagged human BTN3A3 recombinant protein
Secondary
All lanes:
Dot Blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
false
Exposure time: 26s
Related conjugates and formulations (1)
-
Anti-BTN3A1 + BTN3A2 + BTN3A3 antibody [EPR28070-58]
Reactivity data
Product details
ab319102 is the carrier-free version of ab319101.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
BTN3A proteins influence activation and proliferation of gamma delta T cells which are critical for immune surveillance against pathogens and tumors. BTN3A1 BTN3A2 and BTN3A3 together form complexes essential for this function. By facilitating recognition of phosphoantigens these proteins modulate immune activation impacting T cell responses. BTN3A proteins serve as important players in immune regulation enabling cells to recognize and respond effectively to tumors and infections.
Pathways
BTN3A proteins participate in the modulation of the immune checkpoint pathway impacting T cell receptor signaling and the immune-suppressive tumor microenvironment. They interact with proteins like Perforin 1 which play important roles in immune responses. These interactions not only regulate immune activation but also influence tumor immune evasion processes making BTN3A proteins significant in cancer immunotherapy research.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com